Author: The AI Report - Bewertung: 1242x - Views:42664
Sam Altman's new longevity company promises to reverse people's age by 2-3 decades within the next 3 years by making use of the newest developments in the field of longevity sciences.
Backed by an impressive $180 million, Altman's new Company Retro Biosciences is not just about extending lifespans but also about reshaping the very approach to longevity research. Diverging from the conventional path of singular-focused therapies, Retro is simultaneously exploring five distinct avenues, from autophagy to cell rejuvenation also called the yamanaka factors. Their innovative strategies have seen them transform an abandoned retail space into a cutting-edge laboratory, all while operating largely under the radar until now.
Yet, as tantalizing as the promise of extended life sounds, it's not without its controversies and challenges. With personalities like billionaire Bryan Johnson pushing the boundaries with radical anti-aging regimens, and tales of tri-generational plasma swaps capturing headlines, the quest for a fountain of youth takes on new dimensions. As we delve deeper into the article, we'll uncover the science, the skepticism, and the stories behind this riveting journey towards potentially rewriting the narrative of human lifespan.
-----
Every day is a day closer to the Technological Singularity. Experience Robots learning to walk & think, humans flying to Mars and us finally merging with technology itself. And as all of that happens, we at AI News cover the absolute cutting edge best technology inventions of Humanity.
-----
TIMESTAMPS:
00:00 The first ever Age Reversal Treatment
01:04 How Sam Altman's Longevity Company works
06:10 Retro Biosciences Longevity Controversy
-----
#longevity #samaltman #biotechnology
SOCIAL SHARE CARD GENERATOR